Literature DB >> 6403939

Alternative forms of lethality in mitomycin C-induced bacteria carrying ColE1 plasmids.

J L Suit, M L Fan, J F Sabik, R Labarre, S E Luria.   

Abstract

We have studied the physiological effects of mitomycin C induction on cells carrying ColE1 plasmids with differing configurations of three genes: the structural gene coding for colicin (cea), a gene responsible for mitomycin C lethality (kil) that we located as part of an operon with cea, and the immunity (imm) gene, which lies near cea but is not in the same operon. kil is close to or overlaps imm. When cea(+) plasmids are present mitomycin C induction results in 100-fold or greater increases in the level of colicin. Within an hour after induction more than 90% of cells carrying cea(+)kil(+) plasmids are killed and macromolecular synthesis stops, capacity for transport of proline, thiomethyl beta-D-galactoside, and alpha-methyl glucoside is lost, and the membrane becomes abnormally permeable as indicated by an increased accessibility of intracellular beta-galactosidase to the substrate o-nitrophenyl beta-D-galactoside. All of these events occur when a cea(-)kil(+)imm(+) plasmid is present and none does when the plasmid is cea(+)kil(-)imm(+), so the damage can be attributed solely to the Kil function and not to the presence of colicin. However, cells carrying a cea(+)kil(-)imm(-) plasmid are killed upon induction, apparently by action of endogenous colicin on the nonimmune cytoplasmic membrane. The pattern of accompanying physiological damage is distinguished from the kil(+)-associated damage by an enhancement of alpha-methyl glucoside uptake and accumulation and efflux of alpha-methyl glucoside 6-phosphate and by an absence of the alteration in membrane permeability for o-nitrophenyl beta-D-galactoside. These features are typical of colicin E1 action on the membrane. The induced damage is not prevented by trypsin and occurs in cells of a strain specifically tolerant to exogenous colicin E1, indicating that the attack is from inside the cell.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403939      PMCID: PMC393423          DOI: 10.1073/pnas.80.2.579

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Characterization of in vitro transcription initiation and termination sites in Col E1 DNA.

Authors:  R K Patient
Journal:  Nucleic Acids Res       Date:  1979-06-25       Impact factor: 16.971

2.  Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis.

Authors:  P A Sharp; B Sugden; J Sambrook
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

3.  Genetics and physiology of colicin-tolerant mutants of Escherichia coli.

Authors:  R Nagel de Zwaig; S E Luria
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

4.  Lysis defective mutants of bacteriophage lambda: on the role of the S function in lysis.

Authors:  R W Reader; L Siminovitch
Journal:  Virology       Date:  1971-03       Impact factor: 3.616

5.  Physiological studies on the t gene defect in T4-infected Escherichia coli.

Authors:  R Josslin
Journal:  Virology       Date:  1971-04       Impact factor: 3.616

6.  Mutant of Escherichia coli defective in response to colicin K and in active transport.

Authors:  C A Plate
Journal:  J Bacteriol       Date:  1976-02       Impact factor: 3.490

7.  Mechanism of export of colicin E1 and colicin E3.

Authors:  K S Jakes; P Model
Journal:  J Bacteriol       Date:  1979-06       Impact factor: 3.490

8.  Isolation and characterization of replication-deficient mutants of ColE1 plasmids.

Authors:  T Hashimoto-Gotoh; J Inselburg
Journal:  J Bacteriol       Date:  1979-08       Impact factor: 3.490

9.  Effects of colicins E1 and K on transport systems.

Authors:  K L Fields; S E Luria
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

10.  Effects of colicins K and E1 on the glucose phosphotransferase system.

Authors:  A M Jetten
Journal:  Biochim Biophys Acta       Date:  1976-08-13
View more
  32 in total

1.  Colicin M is only bactericidal when provided from outside the cell.

Authors:  R E Harkness; V Braun
Journal:  Mol Gen Genet       Date:  1990-06

2.  Competitive interactions in Escherichia coli populations: the role of bacteriocins.

Authors:  Hadeel Majeed; Osnat Gillor; Benjamin Kerr; Margaret A Riley
Journal:  ISME J       Date:  2010-07-22       Impact factor: 10.302

3.  Anaerobic control of colicin E1 production.

Authors:  J M Eraso; G M Weinstock
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

4.  Genetic study of the functional organization of the colicin E1 molecule.

Authors:  J L Suit; M L Fan; C Kayalar; S E Luria
Journal:  J Bacteriol       Date:  1985-03       Impact factor: 3.490

5.  Temporal control of colicin E1 induction.

Authors:  B Salles; J M Weisemann; G M Weinstock
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.490

6.  Probable detection of kil peptide derived from colicin E1 plasmid in the envelope fraction of Escherichia coli HB101 carrying pEAP31.

Authors:  R Aono
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

7.  Colicin synthesis and cell death.

Authors:  R Spangler; S P Zhang; J Krueger; G Zubay
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

8.  Localization of the immunity protein-reactive domain in unmodified and chemically modified COOH-terminal peptides of colicin E1.

Authors:  L J Bishop; E S Bjes; V L Davidson; W A Cramer
Journal:  J Bacteriol       Date:  1985-10       Impact factor: 3.490

9.  Genetic analysis of ColN plasmid determinants for colicin production, release, and immunity.

Authors:  A P Pugsley
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

10.  Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract.

Authors:  Osnat Gillor; Itamar Giladi; Margaret A Riley
Journal:  BMC Microbiol       Date:  2009-08-12       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.